Drug profile · INN
flunisolide
FLUNISOLIDE
flunisolide (FLUNISOLIDE) is a glucocorticoid receptor agonist. Associated with Teva Pharma GmbH. Route of administration: inhalation. Current US regulatory status: approved.
Drug details — flunisolide
- US status
- approved
- Class
- —
- Route
- INHALATION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
flunisolide (FLUNISOLIDE) is a glucocorticoid receptor agonist. Associated with Teva Pharma GmbH. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is flunisolide?
flunisolide (FLUNISOLIDE) is a glucocorticoid receptor agonist. Associated with Teva Pharma GmbH. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for flunisolide?
FLUNISOLIDE is a marketed brand name for flunisolide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of flunisolide?
flunisolide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.